Advancements in Breast Cancer Treatment | PBCC 2024
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Register now and explore groundbreaking advancements in breast cancer treatment at PBCC 2024. Stay informed with the latest innovations shaping the future of breast cancer care and research.
The NCI SBIR Innovation Lab podcast reaches and engages with entrepreneurs of all levels to share insights on commercialization and success stories from biotech industry…
Through clinical research led by our Katy Rezvani, M.D., Ph.D., CAR NK cell therapy has now become an experimental treatment option for multiple cancers . Learn…
Join the ASTCT President, Dr. Corey Cutler, for a quarterly Town Hall to learn more about ongoing efforts within
May 22, 2024: Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement
Matthew T. Campbell, MD, MS, discusses CAR T-cell therapy and immunotherapy advances in renal cell carcinoma.
Ashwin Kishtagari, MD, discusses the treatment of patients with myelofibrosis following progression on ruxolitinib.
Nature Reviews Cancer – Author Correction: Developmental origins shape the paediatric cancer genome
Discuss efficacy and safety results from QuANTUM-First, which was a phase 3, randomized, double-blind, placebo-controlled trial exploring VANFLYTA in patients with newly diagnosed FLT3-ITD+ AML…
RAG-01 has received an FDA fast track designation and is being investigated for the treatment of non-muscle invasive bladder cancer.